Variant report
Variant | esv1005641 |
---|---|
Chromosome Location | chr2:113720402-113728169 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:15)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:15 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr2:113724613-113724801 | K562 | blood: | n/a | n/a |
2 | CEBPB | chr2:113720388-113720637 | Hela-S3 | cervix: | n/a | n/a |
3 | CEBPB | chr2:113720379-113720688 | K562 | blood: | n/a | n/a |
4 | FOS | chr2:113720348-113720676 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | FOS | chr2:113720348-113720684 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | FOS | chr2:113720405-113720604 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | FOS | chr2:113720398-113720690 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | FOXA2 | chr2:113724682-113724873 | HepG2 | liver: | n/a | n/a |
9 | KAP1 | chr2:113724664-113724870 | K562 | blood: | n/a | n/a |
10 | MAFK | chr2:113726949-113727085 | HepG2 | liver: | n/a | chr2:113727015-113727030 |
11 | NFYB | chr2:113724373-113724499 | GM12878 | blood: | n/a | n/a |
12 | POLR2A | chr2:113727522-113727946 | H1-neurons | neurons: | n/a | n/a |
13 | POLR2A | chr2:113727459-113728008 | H1-neurons | neurons: | n/a | n/a |
14 | STAT3 | chr2:113720465-113720577 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | STAT3 | chr2:113720373-113720604 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-IL36G-1 | chr2:113724814-113724969 | ucscGeneNc_uc002tjs_2 |
No data |
No data |
Variant related genes | Relation type |
---|---|
IL36G | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs79033545 | chr2:113720412-113720413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs139452168 | chr2:113720460-113720461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs544627780 | chr2:113720473-113720474 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs182613400 | chr2:113720503-113720504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs187265934 | chr2:113720511-113720512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs144127082 | chr2:113720524-113720525 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs145396482 | chr2:113720537-113720538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs567245139 | chr2:113720565-113720566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs571677723 | chr2:113724866-113724867 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs535000803 | chr2:113724873-113724874 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs538057975 | chr2:113724929-113724930 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs150318085 | chr2:113724934-113724935 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs574692969 | chr2:113724945-113724946 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs137943163 | chr2:113724968-113724969 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs72942482 | chr2:113726437-113726438 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs149419708 | chr2:113726443-113726444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs530385809 | chr2:113726457-113726458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs189919324 | chr2:113726461-113726462 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs573359773 | chr2:113726492-113726493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs375535803 | chr2:113726497-113726498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs555820513 | chr2:113726501-113726502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs369675744 | chr2:113726522-113726523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs377745405 | chr2:113726525-113726526 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs368676185 | chr2:113726528-113726529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs79836460 | chr2:113726537-113726538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs35880601 | chr2:113726580-113726581 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs532012453 | chr2:113726603-113726604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs559054303 | chr2:113726616-113726617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs528150671 | chr2:113726781-113726782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs547850882 | chr2:113726829-113726830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs144807036 | chr2:113726830-113726831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs76830532 | chr2:113726841-113726842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs530480822 | chr2:113726872-113726873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs17607787 | chr2:113726882-113726883 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs114472980 | chr2:113726897-113726898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs371755546 | chr2:113726905-113726906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs540073822 | chr2:113726908-113726909 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs112643571 | chr2:113726915-113726916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs111908553 | chr2:113726926-113726927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs567044323 | chr2:113726937-113726938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs535968255 | chr2:113726943-113726944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs555790030 | chr2:113726964-113726965 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs575551691 | chr2:113727015-113727016 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs142884562 | chr2:113727038-113727039 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs11897907 | chr2:113727061-113727062 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs576708087 | chr2:113727131-113727132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs545619294 | chr2:113727165-113727166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs146086039 | chr2:113727201-113727202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs528233291 | chr2:113727217-113727218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs537596256 | chr2:113727237-113727238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 17483303 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Astrocytoma | 22246337 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ocular motor apraxia | 21572526 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 21549014 | CNVD |
Idiopathic chronic pancreatitis | 21549014 | CNVD |
Mental retardation | 21549014 | CNVD |
Maculopathy | 20981449 | CNVD |
Nephronophthisis | 22470819 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Ischaemic stroke | 16980335 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Nephronophthisis | 17901113 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 17699850 | CNVD |
Ovarian cancer | 17699850 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:113715800-113720600 | Weak transcription | Fetal Intestine Small | intestine |
2 | chr2:113726400-113727000 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
3 | chr2:113726400-113727000 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
4 | chr2:113726400-113727200 | Enhancers | Primary T cells fromperipheralblood | blood |
5 | chr2:113726400-113727400 | Enhancers | Primary T cells from cord blood | blood |
6 | chr2:113726600-113727000 | Enhancers | Primary hematopoietic stem cells | blood |
7 | chr2:113726600-113727000 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
8 | chr2:113726600-113727000 | Enhancers | Primary T helper naive cells from peripheral blood | blood |
9 | chr2:113726600-113727000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr2:113726600-113727200 | Enhancers | Fetal Thymus | thymus |
11 | chr2:113726600-113727400 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |